Sequent Scien.

  • Market Cap: Small Cap
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: INE807F01027
  • NSEID: SEQUENT
  • BSEID: 512529
INR
199.70
-7.73 (-3.73%)
BSENSE

Dec 05

BSE+NSE Vol: 22.97 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationQuarterly Results
Results Snapshot
YoYQoQ
Figures in Cr
Consolidate Quarterly Results
Sep'25
Jun'25
Mar'25
Dec'24
Sep'24
Jun'24
Mar'24
Net Sales
423.99
441.42
401.70
390.81
368.65
390.21
361.20
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
423.99
441.42
401.70
390.81
368.65
390.21
361.20
Raw Material Cost
182.79
179.69
159.00
169.93
135.34
153.10
166.37
Purchase of Finished goods
45.14
52.10
36.60
41.79
65.96
68.22
41.37
(Increase) / Decrease In Stocks
-14.83
2.76
4.14
-9.19
-6.01
-7.03
-13.20
Employee Cost
81.69
79.07
76.81
75.22
67.04
62.05
62.19
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Selling and Distribution Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Expenses
73.52
75.61
78.91
78.56
67.22
71.92
72.20
Total Expenditure (Excl Depreciation)
368.31
389.23
355.46
356.31
329.55
348.26
328.93
Operating Profit (PBDIT) excl Other Income
55.68
52.19
46.24
34.50
39.10
41.95
32.27
Other Income
2.15
3.87
1.66
5.84
4.51
2.68
4.00
Operating Profit (PBDIT)
57.83
56.06
47.90
40.34
43.61
44.63
36.27
Interest
13.51
14.16
15.13
14.95
14.29
16.38
12.44
Exceptional Items
-1.70
-1.25
-0.34
-0.31
-4.32
0.00
-4.71
Gross Profit (PBDT)
42.62
40.65
32.43
25.08
25.00
28.25
19.12
Depreciation
15.46
15.13
16.12
16.98
17.10
16.25
16.48
Profit Before Tax
27.16
25.52
16.31
8.10
7.90
12.00
2.64
Tax
7.56
7.95
5.93
1.62
1.56
2.94
1.37
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
19.60
17.57
10.38
6.48
6.34
9.06
1.27
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
19.60
17.57
10.38
6.48
6.34
9.06
1.27
Share in Profit of Associates
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Minority Interest
4.86
3.26
1.06
3.04
3.73
2.55
2.19
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
14.74
14.31
9.32
3.44
2.61
6.51
-0.92
Equity Capital
50.33
50.07
50.06
50.06
49.92
49.90
49.89
Face Value
2.0
2.0
2.0
2.0
2.0
2.0
2.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Earnings per share (EPS)
0.59
0.57
0.37
0.14
0.1
0.26
-0.04
Diluted Earnings per share
0.58
0.56
0.36
0.13
0.1
0.26
-0.04
Operating Profit Margin (Excl OI)
13.13%
11.82%
11.51%
8.83%
10.61%
10.75%
8.93%
Gross Profit Margin
10.05%
9.21%
8.07%
6.42%
6.78%
7.24%
5.29%
PAT Margin
4.62%
3.98%
2.58%
1.66%
1.72%
2.32%
0.35%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Quarterly Analysis Highlights - YoY
stock-summary

Net Sales

YoY Growth in quarter ended Sep 2025 is 15.01% vs 6.56% in Sep 2024

stock-summary

Consolidate Net Profit

YoY Growth in quarter ended Sep 2025 is 464.75% vs 131.15% in Sep 2024

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in quarter ended Sep 2025 is 42.40% vs 158.43% in Sep 2024

stock-summary

Interest

YoY Growth in quarter ended Sep 2025 is -5.46% vs 13.59% in Sep 2024

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024

Compare Quarterly Results Of Sequent Scien. With
Markets Mojo
Figures in Cr
Consolidate Quarterly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
423.99
0
423.99
Other Operating Income
0.00
0.00
0.00
Total Operating income
423.99
0
423.99
Raw Material Cost
182.79
0
182.79
Purchase of Finished goods
45.14
0
45.14
(Increase) / Decrease In Stocks
-14.83
0
-14.83
Employee Cost
81.69
0
81.69
Power Cost
0.00
0
0.00
Manufacturing Expenses
0.00
0
0.00
Selling and Distribution Expenses
0.00
0
0.00
Other Expenses
73.52
0.00
73.52
Total Expenditure (Excl Depreciation)
368.31
0
368.31
Operating Profit (PBDIT) excl Other Income
55.68
0.00
55.68
Other Income
2.15
0
2.15
Operating Profit (PBDIT)
57.83
0
57.83
Interest
13.51
0
13.51
Exceptional Items
-1.70
0
-1.70
Gross Profit (PBDT)
42.62
0
42.62
Depreciation
15.46
0
15.46
Profit Before Tax
27.16
0
27.16
Tax
7.56
0
7.56
Provisions and contingencies
0.00
0
0.00
Profit After Tax
19.60
0
19.60
Extraordinary Items
0.00
0
0.00
Prior Period Expenses
0.00
0
0.00
Other Adjustments
0.00
0
0.00
Net Profit
19.60
0
19.60
Share in Profit of Associates
0.00
0
0.00
Minority Interest
4.86
0
4.86
Other related items
0.00
0.00
0.00
Consolidated Net Profit
14.74
0
14.74
Equity Capital
50.33
0
50.33
Face Value
2.00
0
0.00
Reserves
0.00
0
0.00
Earnings per share (EPS)
0.59
0
0.59
Diluted Earnings per share
0.58
0
0.58
Operating Profit Margin (Excl OI)
13.13%
0%
0.00
13.13%
Gross Profit Margin
10.05%
0%
0.00
10.05%
PAT Margin
4.62%
0%
0.00
4.62%
Public Share Holdings (%)
0.00%
0%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0%
0.00
0.00%
Quarterly - Net Sales
Net Sales 423.99 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -3.95% vs 9.89% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 15.01% vs 6.56% in Sep 2024

Quarterly - Consolidate Net Profit
Consolidate Net Profit 14.74 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 3.00% vs 53.54% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 464.75% vs 131.15% in Sep 2024

Quarterly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 55.68 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is 6.69% vs 12.87% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is 42.40% vs 158.43% in Sep 2024

Quarterly - Interest
Interest 13.51 Cr
in Sep 2025

Figures in Cr
stock-summary

QoQ Growth in quarter ended Sep 2025 is -4.59% vs -6.41% in Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 is -5.46% vs 13.59% in Sep 2024

Quarterly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 13.13%
in Sep 2025

Figures in %
stock-summary

QoQ Growth in quarter ended Sep 2025 has improved from Jun 2025

stock-summary

YoY Growth in quarter ended Sep 2025 has improved from Sep 2024